硼中子俘获疗法治疗皮肤恶性肿瘤的研究进展OA
Advances in boron neutron capture therapy for cutaneous malignancies
硼中子俘获疗法(BNCT)是一种治疗恶性肿瘤的有效治疗方法,目前已在各种皮肤恶性肿瘤疾病中取得较好的治疗效果.BNCT 治疗恶性黑色素瘤的多中心研究显示其完全缓解率可达 73%~78%,总体疾病控制率高达 88%,患者总体 5 年疾病特异性生存率为 58%,且对皮肤损伤等不良反应可控.对于生殖器区域黑色素瘤及乳腺外佩吉特病,BNCT 治疗疗效显著.在皮肤血管肉瘤的首次人体Ⅰ期临床试验中,BNCT 治疗的最佳总体缓解率达 70%,2 年总生存率为 90.0%.此外,BNCT 在皮肤转移性肿瘤等疾病中也显示出较好的治疗效果.本文主要概括 BNCT 在皮肤恶性肿瘤治疗方面的临床研究进展,系统探讨 BNCT 治疗皮肤恶性肿瘤的可行性及可发展性.
As an effective therapeutic strategy for malignant neoplasms,boron neutron capture therapy(BNCT)has demonstrated promising clinical outcomes across various cutaneous malignan-cies.Multicenter studies in melanoma have reported complete response rates of 73%-78%,an overall disease control rate of 88%,and a 5-year disease-specific survival of 58%,with managea-ble toxicities including cutaneous radiation injury.For genital melanoma and extramammary Paget disease,BNCT has shown promising efficacy.In the first-in-human phase Ⅰ trial for cutaneous angiosarcoma,BNCT achieved a best overall response rate of 70%and a 2-year overall survival rate of 90.0%.Additionally,BNCT has exhibited therapeutic potential in cutaneous metastases and soft tissue sarcomas with cutaneous or subcutaneous involvement.This review systematically summarizes clinical advances in BNCT for cutaneous malignancies and discusses its clinical feasi-bility,current limitations,and future prospects.
黄翠儿;刘文琪;李常兴
南方医科大学第十附属医院(东莞市人民医院),广东 东莞 523000南方医科大学第十附属医院(东莞市人民医院),广东 东莞 523000南方医科大学第十附属医院(东莞市人民医院),广东 东莞 523000
硼中子俘获疗法硼中子载体皮肤恶性肿瘤
boron neutron capture therapyboron delivery agentscutaneous malignancies
《皮肤性病诊疗学杂志》 2026 (8)
628-632,5
评论